SHA:600513 Market Cap

SHA:600513 has a market cap or net worth of 6.70 billion as of March 10, 2026. Its market cap has increased by 132.94% in one year.

Market Cap

6.70B

Enterprise Value

8.31B

Revenue

2.60B

Ranking

n/a

PE Ratio

n/a

Stock Price

23.10

Market Cap Chart

Since March 19, 2003, SHA:600513's market cap has increased from 1.11B to 6.70B, an increase of 501.88%. That is a compound annual growth rate of 8.12%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	6.70B	28.24%
Dec 31, 2025	5.23B	84.76%
Dec 31, 2024	2.83B	-11.04%
Dec 29, 2023	3.18B	17.94%
Dec 30, 2022	2.70B	-3.08%
Dec 31, 2021	2.78B	-6.30%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ChengDa Pharmaceuticals	6.48B
Beijing SL Pharmaceutical	6.43B
Jinghua Pharmaceutical Group	6.36B
Tibet Duo Rui Pharmaceutical	6.62B
Guizhou Xinbang Pharmaceutical	6.32B
Shanghai Kaibao Pharmaceutical CO.,Ltd	6.76B
HPGC Renmintongtai Pharmaceutical	6.13B
Beijing Beilu Pharmaceutical	6.11B

Market Cap Rankings